Which Nostril Should be Used for Nasotracheal Intubation With Airtraq NT®: the Right or Left? A Randomized Clinical Trial

Nasotracheal Intubation Clinical Trial

Official title:

Which Nostril Should be Used for Nasotracheal Intubation With Airtraq NT®: the Right or Left? A Randomized Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03226002
• Other study ID #: KÜ GOKAEK 2017/71
• Status: Completed
• Phase: N/A
• Start date: April 1, 2017
• Est. completion date: September 10, 2017

Study information

• Verified date: August 2018
• Source: Kocaeli University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

After Ethics committee approval investigators decided to enroll 40 patients ASA I-II, 18-60 years of age undergoing maxillofascial, oral and double chin surgery to determine which nostril is more suitable for nasotracheal intubation with nasotracheal Airtraq. We primay aimed to compare the glottis visualization time, intubation time and total intubation times.

Description:

After Ethics committee approval, investigators decided to enroll 40 pateints ASA I-II, 18-60 years of age undergoing maxillofascial, oral and double chin surgery to determine which nostril is more suitable for nasotracheal intubation with nasotracheal Airtraq. In addition is the 90° anti-clockwise rotation of the tip of the tube helpful to insert the tube into the trachea. Patients were randomized into right and the left nostril groups. After standard anesthesia induction with propofol and fentanyl, rocuronium was used for muscle relaxation. Primary aim of this prospective study was to compare the glottis visualization time, intubation time and total intubation times. The Cormack-Lehane grades, the need for optimization, tube adjustment maneuvers, hemodynamic data, occurrence of epistaxis of the patients were recorded during the process.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 35
• Est. completion date: September 10, 2017
• Est. primary completion date: September 1, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• 18-65 years of age

• undergoing elective maxillofacial surgery

• dental surgery

• plastic surgery requiring nasotracheal intubation

• ASA I-II

Exclusion Criteria:

• >18 years and > 65 years

• BMI> 35

• ASA III-IV

• fasted patients

• patients do not require nasotracheal intubation

Related Conditions & MeSH terms

• Nasotracheal Intubation

Intervention

Device:
• Airtraq NT
channeled video laryngoscope for nasotracheal intubation

Locations

Country	Name	City	State
Turkey	Kocaeli University School of Medicine	Kocaeli

Sponsors (1)

Lead Sponsor	Collaborator
Kocaeli University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	insertion time of the device	handling the device till the optimal glottis visualization occurred	20 seconds
Primary	nasotracheal intubation time with the device	handling the device till the visualization of tracheal tube through the vocal cords	30 seconds
Primary	total nasotracheal intubation time with the device	handling the device till the confirmation of nasotracheal intubation with end-tidal carbodioxide	40 seconds
Secondary	optimisation maneuvers during intubation with the device	need for optimisation maneuvers during nasotracheal intubation	20 seconds
Secondary	minor complications related to the device	epistaxis, nose pain, bronchospasm	40 seconds